Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
Renewing interest in immune aspects of schizophrenia and new findings about the brain-fat axis encourage us to discuss the possible role of interleukin-6 (IL-6) in schizophrenia. Previously, it was suggested that a primary alteration of the innate immune system may be relevant in schizophrenia. Func...
Main Authors: | Milica Milovan Borovcanin, Ivan Jovanovic, Gordana Radosavljevic, Jelena Pantic, Slavica Minic Janicijevic, Nebojsa Arsenijevic, Miodrag L. Lukic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-11-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fpsyt.2017.00221/full |
Similar Items
-
Possible Role of TGF – B Pathways in Schizophrenia / Moguća Uloga TTGF - B Signalnih Puteva U Shizofreniji
by: Borovcanin Milica, et al.
Published: (2016-03-01) -
IL-33/ST2 Pathway and Galectin-3 as a New Analytes in Pathogenesis and Cardiometabolic Risk Evaluation in Psychosis
by: Milica M. Borovcanin, et al.
Published: (2018-06-01) -
Interplay of Brain-Derived Neurotrophic Factor and Cytokines in Schizophrenia
by: Janicijevic Slavica Minic, et al.
Published: (2020-12-01) -
Interleukin-33/ST2: A new signaling pathway in immunity and immunopathology
by: Pavlović Slađana, et al.
Published: (2012-01-01) -
Type 17 Immune Response Facilitates Progression of Inflammation and Correlates with Cognition in Stable Schizophrenia
by: Milica M. Borovcanin, et al.
Published: (2020-11-01)